Intracranial hemorrhage in patients with primary brain cancer receiving anticoagulation.

Saved in:
Bibliographic Details
Title: Intracranial hemorrhage in patients with primary brain cancer receiving anticoagulation.
Authors: Hamulyák EN; Department of Hematology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands., Wang TF; Department of Medicine, University of Ottawa at The Ottawa Hospital and Ottawa Hospital Research Institute, Ottawa, ON, Canada., Kreuziger LB; Versiti Blood Research Institute and Medical College of Wisconsin, Milwaukee, WI., Iyengar V; Division of Hematology and Hematologic Malignancies, Beth Israel Deaconess Medical Center, Boston, MA.; Hematology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Carney BJ; Division of Hematology and Hematologic Malignancies, Beth Israel Deaconess Medical Center, Boston, MA., Hoeben A; Division of Medical Oncology, Department of Internal Medicine, GROW-School of Oncology and Developmental Biology, Maastricht University Medical Center+, Maastricht, The Netherlands., Özdemir BC; Department of Medical Oncology, Inselspital Bern, Bern University Hospital, University of Bern, Bern, Switzerland., Cordova Serrano RD; Department of Hematology, Instituto Nacional de Cancerología, Mexico City, Mexico., Sanfilippo KM; Division of Hematology, Washington University School of Medicine and Saint Louis Veterans Administration Medical Center, St. Louis, MO., Rozenblatt S; Department of Radiology, Rabin Medical Center, Petah Tikva, Israel., Beenen LFM; Department of Radiology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands., Yust-Katz S; Neurooncology Unit, Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel.; Faculty of Medicine and Health Sciences, Tel Aviv University, Tel Aviv, Israel., Halperin E; Faculty of Medicine and Health Sciences, Tel Aviv University, Tel Aviv, Israel.; Institute of Hematology, Rabin Medical Center, Petah Tikva, Israel., Arad A; Hematology Department, Hadassah-Hebrew University Medical Center, Jerusalem, Israel., Lubetsky A; Faculty of Medicine and Health Sciences, Tel Aviv University, Tel Aviv, Israel.; National Hemophilia Center and Thrombosis & Hemostasis Institute, Sheba Medical Center, Ramat Gan, Israel., Carrier M; Department of Medicine, University of Ottawa at The Ottawa Hospital and Ottawa Hospital Research Institute, Ottawa, ON, Canada., Massat B; Versiti, Medical College of Wisconsin, Milwaukee, WI., Büller HR; Department of Hematology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands., Spectre G; Faculty of Medicine and Health Sciences, Tel Aviv University, Tel Aviv, Israel.; Institute of Hematology, Rabin Medical Center, Petah Tikva, Israel., Zwicker JI; Hematology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Leader A; Hematology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Faculty of Medicine and Health Sciences, Tel Aviv University, Tel Aviv, Israel.; Institute of Hematology, Rabin Medical Center, Petah Tikva, Israel.
Corporate Authors: ABC Study Group
Source: Blood vessels, thrombosis & hemostasis [Blood Vessel Thromb Hemost] 2026 Jan 20; Vol. 3 (2), pp. 100140. Date of Electronic Publication: 2026 Jan 20 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 9918957761606676 Publication Model: eCollection Cited Medium: Internet ISSN: 2950-3272 (Electronic) Linking ISSN: 29503272 NLM ISO Abbreviation: Blood Vessel Thromb Hemost Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2950-3272
DOI:10.1016/j.bvth.2026.100140